Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.

This morning, we're focusing on a health issue that impacts millions of men and their families every year. Prostate cancer. We speak with doctors and a patient about the symptoms and treatment options ...

So, what is the prostate and why does it cause so many problems for men? It's a topic most people don't want to discuss. But it can have a big impact on your life. The prostate is a small organ that ...

While prognoses for prostate cancer patients were once measured in months, experts say that advances in treatment and diagnosis now improve survival by years. By Gina Kolata Prostate cancer experts ...

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...

Professor Prabhakar Rajan has spoken out about the concerning rate of prostate cancer diagnoses and the one thing he wants men to do to tackle it ...

Some doctors say they are surprised the condition was found at all in the former president, given his age. By Gina Kolata May 18: Read an updated article about Former President Biden’s prostate cancer ...

At 7.3 years’ median follow-up, cabazitaxel failed to improve clinical PFS (62.8% vs 67.2%), metastasis-free survival, or overall survival versus androgen deprivation therapy plus radiotherapy.